Search research articles
Contact Us
Filters
Showing results (61-70 of 375) with videos related to
Page
of 38
Sort By:
Expert Review of Anticancer Therapy
|
November 25, 2016
Adjuvant trastuzumab: a 10-year overview of its benefit
Matteo Lambertini, Noam F Pondé, Cinzia Solinas, et al.
Cancer Treatment Reviews
|
November 29, 2015
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Lucia Del Mastro, Giovanni Rossi, Matteo Lambertini, et al.
Clinical Medicine Insights. Reproductive Health
|
March 20, 2019
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
Matteo Lambertini, François Richard, Bastien Nguyen, et al.
Journal of Thoracic Disease
|
July 3, 2013
Fertility counseling of young breast cancer patients
Matteo Lambertini, Paola Anserini, Alessia Levaggi, et al.
Expert Opinion on Drug Safety
|
July 12, 2017
Breast cancer treatment-induced cardiotoxicity
Samuel Martel, Christian Maurer, Matteo Lambertini, et al.
European Journal of Clinical Investigation
|
March 28, 2022
Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue
Matteo Lambertini, Camilla Marrocco, Stefano Spinaci, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2024
Tackling Non-Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes
Juan Carlos Laguna, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 9, 2021
Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
Elisa Agostinetto, Marcello Ceppi, Marco Bruzzone, et al.
Expert Opinion on Pharmacotherapy
|
June 21, 2016
News on the medical treatment of young women with early-stage HER2-negative breast cancer
Matteo Lambertini, Francesca Poggio, Marina Vaglica, et al.
Breast (Edinburgh, Scotland)
|
July 24, 2017
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Cinzia Solinas, Luisa Carbognin, Pushpamali De Silva, et al.
Page
of 38
Search research articles
Search
Showing results (61-70 of 375) with videos related to
Sort By:
Page
of 38
Expert Review of Anticancer Therapy
|
November 25, 2016
Adjuvant trastuzumab: a 10-year overview of its benefit
Matteo Lambertini, Noam F Pondé, Cinzia Solinas, et al.
Cancer Treatment Reviews
|
November 29, 2015
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Lucia Del Mastro, Giovanni Rossi, Matteo Lambertini, et al.
Clinical Medicine Insights. Reproductive Health
|
March 20, 2019
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
Matteo Lambertini, François Richard, Bastien Nguyen, et al.
Journal of Thoracic Disease
|
July 3, 2013
Fertility counseling of young breast cancer patients
Matteo Lambertini, Paola Anserini, Alessia Levaggi, et al.
Expert Opinion on Drug Safety
|
July 12, 2017
Breast cancer treatment-induced cardiotoxicity
Samuel Martel, Christian Maurer, Matteo Lambertini, et al.
European Journal of Clinical Investigation
|
March 28, 2022
Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue
Matteo Lambertini, Camilla Marrocco, Stefano Spinaci, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2024
Tackling Non-Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes
Juan Carlos Laguna, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 9, 2021
Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
Elisa Agostinetto, Marcello Ceppi, Marco Bruzzone, et al.
Expert Opinion on Pharmacotherapy
|
June 21, 2016
News on the medical treatment of young women with early-stage HER2-negative breast cancer
Matteo Lambertini, Francesca Poggio, Marina Vaglica, et al.
Breast (Edinburgh, Scotland)
|
July 24, 2017
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Cinzia Solinas, Luisa Carbognin, Pushpamali De Silva, et al.
Page
of 38